Sterically Controlled C–H Borylation and Silylation of (Hetero)arenes Using Pyrazolonaphthyridine Ligands
Synthesis · 01.09.2025 · 57 (18) · 2716-2726
DOI: 10.1055/a-2641-8612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 01.09.2025. Verfasst von Eunsu Kang und 2 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
We have developed iridium-catalyzed C–H borylation and silylation reactions using pyrazolonaphthyridine (PzNPy) ligands. The readily tunable PzNPy system provides easy control of the ligand characteristics, enabling selective functionalization at the least hindered positions. With the new catalytic system, 1,4-disubstituted and multi-substituted toluene derivatives preferentially underwent borylation at benzylic positions, whereas 1,3-disubstituted arenes favored the least hindered sp2 positions. The Ir/PzNPy system also showed applicability in the C–H borylation of heteroarenes and metallocenes. Furthermore, increasing steric bulk near nitrogen atoms of ligand enabled C–H silylation of five-membered heteroarenes. These results expand the toolbox of bidentate nitrogen ligands for the development of iridium-catalyzed C–H functionalization reactions, suggesting the potential of tailorable PzNPy ligands to extend beyond their applications in palladium catalysis.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kang, E., Jeong, S., & Joo, J. M. (2025). Sterically Controlled C–H Borylation and Silylation of (Hetero)arenes Using Pyrazolonaphthyridine Ligands. Synthesis, 57(18), 2716-2726. https://doi.org/10.1055/a-2641-8612
Vancouver
Kang E, Jeong S, Joo JM. Sterically Controlled C–H Borylation and Silylation of (Hetero)arenes Using Pyrazolonaphthyridine Ligands. Synthesis. 2025;57(18):2716-2726. doi:10.1055/a-2641-8612
BibTeX
@article{Kang2025,
author = {Kang, Eunsu and Jeong, Siyeon and Joo, Jung Min},
title = {Sterically Controlled C–H Borylation and Silylation of (Hetero)arenes Using Pyrazolonaphthyridine Ligands},
journal = {Synthesis},
year = {2025},
volume = {57},
number = {18},
pages = {2716--2726},
doi = {10.1055/a-2641-8612}
}
EUVIMED